Position in PTCT
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$45,928,746
-$22,829,633 QoQ
Shares Held
674,134
-25.5% QoQ
Ownership
0.813%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 92.2611824948749.ToString("F0")%
Shared 0.ToString("F0")%
None 7.738817505125094.ToString("F0")%
Common Shares in PTCT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026MORGAN STANLEY holds $15,440,401,210 across 521 Biotechnology names. PTCT ranks #58 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RPRX |
Royalty Pharma plc
|
43,571,633 | $2,090,131,227 | |
| 2 | ROIV |
Roivant Sciences Ltd.
|
51,828,325 | $1,435,644,595 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,188,881 | $1,423,962,911 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,319,329 | $1,019,366,352 | |
| 5 | TECH |
BIO-TECHNE Corp
|
8,532,873 | $445,927,935 | |
| 6 | MRNA |
Moderna, Inc.
|
8,471,263 | $430,340,154 | |
| 7 | ARGX |
Argenx SE
|
560,711 | $409,459,203 | |
| 8 | APLS |
Apellis Pharmaceuticals, Inc.
|
10,042,399 | $404,005,708 |
All Filings in PTCT
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $45,928,746 | 674,134 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $68,758,379 | 905,192 | Shares | Defined | 2026-05-27 | |
| 2025-09-30 | $25,739,619 | 419,417 | Shares | Defined | 2026-05-27 | |
| 2025-06-30 | $56,817,472 | 1,163,339 | Shares | Defined | 2025-08-15 | |
| 2025-03-31 | $48,383,153 | 949,434 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $48,472,096 | 1,073,817 | Shares | Defined | 2025-05-15 | |
| 2024-09-30 | $42,963,800 | 1,158,054 | Shares | Defined | 2025-05-14 | |
| 2024-06-30 | $46,382,425 | 1,516,757 | Shares | Defined | 2025-05-14 | |
| 2024-03-31 | $60,013,858 | 2,063,041 | Shares | Defined | 2024-10-17 | |
| 2023-12-31 | $34,346,894 | 1,246,259 | Shares | Defined | 2024-08-16 | |
| 2023-09-30 | $9,764,931 | 435,740 | Shares | Defined | 2023-11-15 | |
| 2023-06-30 | $15,498,357 | 381,076 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $10,942,108 | 225,890 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $11,361,868 | 297,665 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $14,269,298 | 284,249 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $17,000,939 | 424,387 | Shares | Defined | 2022-10-27 | |
| 2022-03-31 | $12,817,250 | 343,534 | Shares | Defined | 2022-10-27 | |
| 2021-12-31 | $8,591,925 | 215,715 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $1,560,956 | 41,950 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $7,586,659 | 179,481 | Shares | Defined | 2021-08-23 | |
| 2021-03-31 | $885,585 | 18,703 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $3,165,992 | 51,876 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $928,173 | 19,854 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $1,437,868 | 28,338 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $3,830,749 | 85,872 | Shares | Defined | 2020-05-26 | |
| No filing history on record for this holder in this stock. | ||||||